Evidence map›Paper›PMID 33980605›Full record

ArticleDiabetes care2021

Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.

Rose Gubitosi-Klug, Xiaoyu Gao, Rodica Pop-Busui, Ian H de Boer, Neill White, Lloyd P Aiello, Ryan Miller, Jerry Palmer, William Tamborlane, Amisha Wallia and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Increased intracellular miR-142 in adults with Type 1 diabetes.Journal of diabetes and its complications · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

Rose Gubitosi-KlugPediatric Endocrinology, UH Rainbow Babies and Children's Hospital, Cleveland, OH.ORCID 0000-0002-7376-6870
Xiaoyu GaoBiostatistics Center, Milken Institute School of Public Health, The George Washington University, Rockville, MD.
Rodica Pop-BusuiDivision of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-2042-1350
Ian H de BoerDivision of Nephrology, University of Washington, Seattle, WA.ORCID 0000-0003-1571-7592
Neill WhiteDepartment of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO.
Lloyd P AielloJoslin Diabetes Center, Boston, MA.
Ryan MillerDivision of Pediatric Endocrinology, University of Maryland, Baltimore, MD.
Jerry PalmerDivision of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA.
William TamborlaneDepartment of Pediatrics and Endocrinology, Yale School of Medicine, New Haven, CT.
Amisha WalliaDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.ORCID 0000-0002-3183-4062
Mikhail KosiborodSaint Luke's Mid America Heart Institute, Kansas City, MO.ORCID 0000-0002-3750-9789
John M LachinBiostatistics Center, Milken Institute School of Public Health, The George Washington University, Rockville, MD.ORCID 0000-0001-9838-2841
Ionut BebuBiostatistics Center, Milken Institute School of Public Health, The George Washington University, Rockville, MD ibebu@bsc.gwu.edu.ORCID 0000-0002-4944-7968
DCCT/EDIC Research Group
Milken Institute · USUniversity of Washington · USJoslin Diabetes Center · USNorthwestern University · USRainbow Babies & Children's Hospital · USSaint Luke's Hospital · USUniversity of Maryland, Baltimore · USUniversity of Michigan · USWashington University in St. Louis · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)U01DK094157 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Ionut Bebu, Barbara Halina Braffett · 2011 to 2026
$97.6M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
Epidemiology of Diabetes Interventions and Complications Data Coordinating CenterU01DK094176 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI BEBU, IONUT, BRAFFETT, BARBARA HALINA · 2012 to 2022
$30.8M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK045735NIDDK NIH HHS U01 DK094157NIDDK NIH HHS U01 DK094176
6 · The paper itself

Abstract

objectiveWe examined whether the presence of microvascular complications was associated with increased subsequent risk of cardiovascular disease (CVD) among participants with type 1 diabetes in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study followed for >35 years. RESEARCH DESIGN AND

methodsStandardized longitudinal data collection included:

resultsA total of 239 participants developed CVD, including 120 participants who suffered major adverse cardiovascular events (MACE) defined as nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. The presence of microvascular disease (diabetic retinopathy, kidney disease, or CAN) was associated with increased risk of subsequent CVD and MACE (hazard ratios 1.86 to 3.18 and 2.09 to 3.63, respectively), associations that remained significant after adjusting for age and HbA

conclusionsAdvanced microvascular disease, especially moderate to severe albuminuria or eGFR <60 mL/min/1.73 m

Indexed as

Cardiovascular DiseasesCardiovascular SystemDiabetes ComplicationsDiabetes Mellitus, Type 1HumansRisk Factors

Identifiers

PMID33980605
PMCPMC8323173
OpenAlexW3162453607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.